<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref2">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Adedeji</surname>
    <given-names>A. O.</given-names>
   </name>
   <name>
    <surname>Sarafianos</surname>
    <given-names>S.</given-names>
   </name>
  </person-group> (
  <year>2014</year>). 
  <article-title>Antiviral drugs specific for coronaviruses in preclinical development</article-title>. 
  <source>Curr. Opin. Virol.</source>
  <volume>8</volume>, 
  <fpage>45</fpage>â€“
  <lpage>53</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.coviro.2014.06.002</pub-id>, PMID: 
  <?supplied-pmid 24997250?>
  <pub-id pub-id-type="pmid">24997250</pub-id>
 </mixed-citation>
</ref>
